08/03/2015 - 3:34pm

The National Association of Boards of Pharmacy last week released a progress report urging state and federal regulation for the thousands of websites that illegally distribute medications.

07/31/2015 - 2:06pm

In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.

07/28/2015 - 6:26am

A GAO report released Monday suggests that the Drug Enforcement Agency should take steps to improve communications with pharmacists, manufacturers. 

07/27/2015 - 3:43pm

As the sole U.S. supplier of fluoxymesterone, Upsher-Smith sought a way to renew the product’s availability after the company’s initial API manufacturer discontinued its supply. 

07/27/2015 - 11:19am

The Food and Drug administration announced Friday that it had approved Praluent (alirocumab), a cholesterol-lowering PCSK9 inhibitor injection. 

07/27/2015 - 11:02am

The FDA has approved Daklinza (daclatasvir), in combination with sofosbuvir, in treatment for chronic hepatitis C virus genotype 3 infections.  

07/24/2015 - 12:39pm

The Food and Drug Administration announced Friday that it had approved Novartis’ Odomzo (sonidegib). The drug is meant to treat basal cell carcinoma, the most common form of advanced skin cancer.

07/24/2015 - 12:33pm

The Food and Drug Administration announced Friday that it approved Technivie (ombitasvir, paritaprevir and ritonavir) for use in combination with ribavirin for the treatment of hepatitis C virus (HCV) genotype 4 infections in patients without scarring and cirrhosis.

07/24/2015 - 12:31pm

On Friday, Stichting Preferred Shares Mylan, an independent foundation established in the Netherlands, announced that it would exercise its full call option to purchase 488,388,431 preferred shares in Mylan.